At the end of 2021, the net profit of the pharmaceutical company Pfizer Inc., increased by 2.4 times, to $21.979 billion, Report informs, citing the financial statements of the American corporation.
Diluted earnings per share for the year were $3.85 compared to $1.63 per share a year earlier. At the same time, Pfizer's revenue for the reporting year doubled to $81.288 billion. Pfizer's 2021 vaccine revenue was $13.914 billion, up from $2 billion in 2020.
According to the results of the fourth quarter, the company received a net profit of $3.393 billion, which is 4 times more than the same period in 2020. On a per-share basis, earnings were $0.59 compared to $0.15 in the fourth quarter of 2020. Pfizer's quarterly revenue doubled to $23.838 billion. Analysts had expected a figure of $24.16 billion.